The 2024 application window, spanning from October through December, witnessed a competitive selection process wherein candidates underwent rigorous document screenings followed by detailed interviews conducted by eminent external experts. This meticulous scrutiny culminated in the identification of one Grand Prize winner and two distinguished recipients of the Inspiration Prize. The monetary endowments are significant: 1,000,000 yen for the Grand Prize and 500,000 yen for each Inspiration Prize winner, sponsored by JEOL Ltd. Beyond the cash rewards, the Grand Prize winner is afforded travel sponsorship for research visits to Poland, fostering international scientific collaboration and exchange.

The essence of the Marie Sklodowska Curie Award resides deeply in its mission to address the unique challenges and opportunities faced by young female researchers during a pivotal phase in their careers. This period typically corresponds to the latter stages of doctoral study and the initial years following the acquisition of doctoral degrees, which are considered the most fertile for setting independent research trajectories. However, it concurrently coincides with potential life events requiring flexibility, such as family responsibilities or societal expectations. By highlighting exemplary female scientists through this award, JST aspires to nurture an environment where passion, resilience, and scientific excellence can flourish harmoniously.

The Grand Prize of the 2024 award was conferred upon Dr. Yukako Fujishiro, Unit Leader at RIKEN’s Center for Emergent Matter Science and Pioneering Research Institute. Dr. Fujishiro’s research is centered on the forefront of condensed matter physics, specifically targeting phase transitions that alter topological order parameters—a conceptual framework vital for understanding exotic states of quantum materials. Her work involves synthesizing novel quantum materials in which topological properties can be manipulated, potentially revolutionizing the development of next-generation electronic devices and social infrastructure systems by enabling robust, energy-efficient computational architectures. Her leadership qualities extend beyond the laboratory, actively fostering young researchers’ development and enhancing the public’s grasp of complex scientific phenomena through effective communication.

Among the Inspiration Prize recipients, Dr. Reika Tei, currently a postdoctoral fellow at Stanford University’s Department of Genetics, has garnered attention for her innovative molecular toolkits designed to probe and manipulate biomolecular dynamics within cells. Her research addresses a central challenge in cell biology: capturing the transient and often stochastic motions of intracellular molecules that underlie cellular function and disease states. By creating bespoke molecular probes, Dr. Tei’s work enables unprecedented real-time observation and control of biomolecular assemblies, pushing the boundaries of synthetic biology and molecular genetics. In addition to her scientific endeavors, Dr. Tei passionately advocates for diversity in the scientific workforce, leveraging her platform to inspire a new generation of international researchers.

The other Inspiration Prize winner, Dr. Airi Yoshimoto, a JSPS Overseas Postdoctoral Fellow affiliated with Stanford University’s Biology Department, has made significant strides in neurobiology even as a graduate student. Her research interrogates the intricate nervous system circuits that govern the autonomic control of heart rate, shedding light on how voluntary modulation of cardiac function is achieved through brain–heart interactions. This interdisciplinary effort bridges neuroscience, physiology, and systems biology, employing cutting-edge techniques such as optogenetics and advanced imaging to map neural pathways with unprecedented precision. Dr. Yoshimoto’s active engagement in international collaborations underscores her role as a global contributor to the field, with promising future prospects as both a researcher and educator.

The Marie Sklodowska Curie Award is more than just a recognition—it is a strategic intervention addressing the gender gap in science, technology, engineering, and mathematics (STEM) sectors in Japan. Gender disparities in research environments have long been documented, often linked to systemic barriers, implicit biases, and limited access to mentorship opportunities. Initiatives like this award aim to dismantle such barriers by spotlighting female researchers’ achievements and providing them with resources crucial for sustained scientific careers. The award also symbolizes Japan’s increasing commitment to integrating diverse perspectives in innovation, thereby promoting a more inclusive ecosystem that is crucial for addressing complex scientific and societal challenges.

Dr. Fujishiro’s pioneering work on quantum materials traverses an esoteric frontier characterized by phenomena such as topological insulators, quantum spin liquids, and exotic superconductors. These materials possess unusual electronic properties resilient to environmental perturbations, which could lead to breakthroughs in fault-tolerant quantum computing and ultra-low-power electronics. By mastering the control over topological phase transitions, Dr. Fujishiro aims to pave the way for devices that surpass conventional silicon-based technologies in performance and efficiency, potentially catalyzing advances in information technologies and sustainable infrastructure.

Dr. Tei’s molecular tools harness the principles of chemical biology to create probes that can illuminate and influence the intracellular milieu dynamically. These tools rely on fluorescence resonance energy transfer (FRET), photo-switchable molecules, and engineered protein interactions that allow researchers to visualize the life cycles of proteins, nucleic acids, and metabolites in vivo. Understanding these dynamics is paramount for elucidating disease mechanisms, including neurodegeneration, cancer, and metabolic disorders, thereby opening avenues for novel therapeutic strategies.

Dr. Yoshimoto’s investigations contribute to the burgeoning field of neurocardiology, a subset of neuroscience focusing on the crosstalk between nervous and cardiovascular systems. Her research employs a multi-modal approach combining electrophysiological recordings, calcium imaging, and computational modeling to decipher how intentional control over heart rate is encoded in the brain. These insights hold potential implications for biofeedback therapies, stress management, and treatment of autonomic dysfunction disorders, showcasing the translational value of her foundational research.

Moreover, the award’s international dimension, exemplified by the Polish research visit offered to Dr. Fujishiro, highlights the importance of cross-border scientific exchanges. Poland, sharing historical ties with Marie Curie, continues to be a vibrant hub for physics and chemistry research, making it an apt destination for fostering collaboration. Such opportunities enable awardees to broaden their scientific horizons, establish international networks, and participate in global knowledge dissemination.

The JSPS Overseas Postdoctoral Fellowship held by Dr. Yoshimoto exemplifies Japan’s strategic investment in supporting its emerging researchers on the global stage. This program facilitates immersion in leading international laboratories, fostering skill development, and enhancing collaborative research endeavors. Recognition through the Marie Sklodowska Curie Award, combined with such fellowships, equips young female scientists with competitive advantages in pursuing academic leadership positions and shaping future scientific agendas.

JST’s initiative underscores a holistic approach, understanding that scientific success is intertwined with career sustainability and personal development. By honoring researchers at this critical career juncture, the Marie Sklodowska Curie Award sends a resounding message about the value of inclusivity, perseverance, and intellectual curiosity. This award not only acknowledges past achievements but also invests in prospective contributions to science and society at large. The voices and visions of these accomplished women will inspire countless others to embark on and persist within scientific careers, fostering a ripple effect that enriches the global scientific landscape.

As these young researchers continue to break new ground in their respective fields—quantum physics, molecular genetics, and neurobiology—they embody the spirit of Marie Curie’s legacy: pushing boundaries, challenging conventions, and illuminating the unknown with tenacity and brilliance. JST’s Marie Sklodowska Curie Award thus serves as a beacon, illuminating pathways for women in science to thrive and lead transformational innovation worldwide.

For further details and updates about the award and the profiles of the winners, interested readers are encouraged to follow announcements by the Japan Science and Technology Agency.

Subject of Research: Quantum materials physics; molecular tools for intracellular dynamics; neurocardiology and brain–heart interactions.

Article Title: Japan Science and Technology Agency Honors Young Female Researchers with the 2024 Marie Sklodowska Curie Award

News Publication Date: 2024

Image Credits: Japan Science and Technology Agency

Keywords: Marie Sklodowska Curie Award, female researchers, Japan Science and Technology Agency, quantum materials, intracellular molecular dynamics, neurocardiology, young scientists, gender equity in STEM, research fellowship, scientific leadership

The Keith Terasaki Mid-Career Innovation Award is designed to recognize mid-career researchers who illuminate various scientific domains through their innovative contributions. This prestigious award carries significant weight, as it not only acknowledges outstanding scientists but also reinforces the importance of entrepreneurial spirit in research. Both recipients have demonstrated a remarkable ability to challenge the status quo, devising solutions and methodologies that promise to transform their respective fields. Each awardee will share a cash prize of $5,000 and has the opportunity to present their groundbreaking work at the Innovation Summit, thus providing a platform for their innovative ideas to reach a broader audience.

Dr. Liangfang Zhang, who serves as the Irwin Jacobs Chancellor’s Endowed Chair Professor at the University of California, San Diego, is celebrated for his trailblazing work in nanoscience and nanomedicine. His research focuses particularly on the development of therapeutic nanoparticles, showcasing the potential of these tiny agents in the fight against critical diseases, including cancers and bacterial infections. His contributions to the field are characterized by a staggering output of 296 peer-reviewed articles and 132 issued and pending patents, further attesting to his status as a leading authority in nanomedicine.

One of Dr. Zhang’s groundbreaking innovations involves the camouflage of nanoparticles using red blood cell (RBC) membranes, enabling these stealthy agents to evade the immune system and deliver drugs to tumors effectively. This paradigm-shifting approach combines natural cellular components with synthetic materials, representing an important milestone in biomimetic drug delivery systems. By collecting and utilizing the membrane from RBCs to coat biodegradable polymeric nanoparticles, Dr. Zhang has opened a new frontier in cancer therapy that highlights the transformative potential of nanotechnology. This pioneering work was detailed in a 2011 publication in the Proceedings of the National Academy of Sciences (PNAS), which has garnered significant citations, underscoring the impact and relevance of his research in the scientific community.

Dr. Aydogan Ozcan, another shining star in the research firmament, is a Chancellor’s Professor at UCLA and a prominent figure in the field of biophotonics. His work straddles the intersection of optics and computational technology, leading to the creation of diagnostic tools that promise widespread applications in biomedical research and health care. Through ingenious integration of mobile technologies and transparent optics, Dr. Ozcan has vastly improved the accessibility of medical diagnostics, thereby making healthcare solutions more affordable and efficient.

Notably, Dr. Ozcan has spearheaded the development of smartphone-based diagnostic devices, including portable microscopes and pathogen sensors. His work has revolutionized histopathology by employing artificial intelligence techniques to automate the staining of tissue samples, a critical process traditionally plagued by time-consuming manual methods. The advent of AI-driven virtual staining is just one example of how Dr. Ozcan’s research is reshaping the landscape of pathologic analysis, potentially expediting diagnosis and treatment in clinical settings.

The profound implications of both Dr. Zhang’s and Dr. Ozcan’s research underscore the commitment of the Terasaki Institute to nurture and promote pioneering research that serves society at large. Through the recognition of such ground-breaking work, the Institute continues to uphold Dr. Keith Terasaki’s vision—one that emphasizes the necessity of translating scientific discoveries into actionable solutions that improve health outcomes and enhance lives.

As these award-winning scientists prepare to present their findings at the upcoming Innovation Summit, the atmosphere is ripe for collaboration and inspiring dialogue. Hosted by the Terasaki Institute, this event promises to foster a discourse that can propel new ideas and innovations forward in the realms of medicine and technology. The summit will serve not only as a venue for showcasing cutting-edge research but also as a gathering of thought leaders eager to discuss the transformative potential that advanced research entails.

In conclusion, the inaugural Keith Terasaki Mid-Career Innovation Award represents a clarion call to the global scientific community, championing innovation that is underpinned by tangible impact. Dr. Zhang and Dr. Ozcan exemplify the spirit of this award, paving the way for future generations of researchers dedicated to making a difference through science. Their commitment to elevating the standards of research while prioritizing real-world applications echoes through their work and will undoubtedly inspire others to follow in their footsteps.

As the Terasaki Institute for Biomedical Innovation plays a pivotal role in the ongoing evolution of biomedicine and technology, it remains a cornerstone for researchers and innovators poised to redefine what is possible in the realm of science.

Subject of Research: Nanomedicine and Biophotonics
Article Title: Innovative Luminaries Honored with Inaugural Keith Terasaki Mid-Career Innovation Award
News Publication Date: February 7, 2025
Web References: terasaki.org
References: Proceedings of the National Academy of Sciences (2011)
Image Credits: Terasaki Institute for Biomedical Innovation

Keywords